People · Operator
Named in public records as an officer, director or promoter · active 2009–2022 · Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Endogastric Solutions Inc | — | Other Health Care | Series C | $177.3M | $557.2M | 2009 |
| Iconic Therapeutics Inc | — | Biotechnology | Series C | $79.0M | $533.7M | 2014 |
| Neovista Inc | — | Other Health Care | Series B | $63.3M | $114.9M | 2009 |
| Theraclone Sciences, Inc. | — | Biotechnology | Series A | $36.7M | $111.3M | 2011 |
| Banyan Infrastructure Corp | — | Other Technology | Series B | $29.0M | $308.7M | 2022 |
| Fountain Therapeutics, Inc. | — | Biotechnology | Series B | $26.9M | $348.5M | 2021 |
William Greene at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William Greene on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Steven Gillis | 1 | 23 |
| Wende Hutton | 1 | 16 |
| Todd Foley | 1 | 12 |
| William Link | 1 | 11 |
| Alex Morgan | 1 | 10 |
| ROBERT GREENE | 1 | 9 |
| David Guyer | 1 | 8 |
| Brent Ahrens | 1 | 7 |
| Scott Ward | 1 | 7 |
| Michael Burke | 1 | 7 |
| Bruce Robertson | 1 | 7 |
| Ryan Schwarz | 1 | 7 |
| Bruce Cohen | 1 | 7 |
| Michael Carusi | 1 | 7 |
| Peter Hirth | 1 | 7 |
| Christopher Mirabelli | 1 | 6 |
| Uri Geiger | 1 | 6 |
| Thierry Thaure | 1 | 5 |
| Lee Wrubel | 1 | 5 |
| Stephen Martin | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.